Is Synlait FPO NZX the next a2 Milk Company Limited?

Synlait FPO NZX's (ASX:SM1) share price is up almost 125% in 2017.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in a2 Milk Company Limited (ASX: A2M) have risen more than 1,100% since it listed on the ASX in March 2015.

If you've missed out on a2 Milk's stellar run, you may want to check out its listed business affiliate, Synlait FPO NZX (ASX: SM1).

Synlait is a dairy processing company based in New Zealand that is a2 Milk's major supplier and also exports finished product to China. A strong business relationship exists between the two firms, with a five-year supply arrangement agreed to in August 2016.

a2 Milk acquired an 8.2% shareholding in Synlait earlier this year to further strengthen the long-term relationship. Shares in Synlait are up more than 115% over the last six months, almost keeping pace with a2 Milk during the same timeframe. 

On 28 September Synlait received CFDA (China Food and Drug Administration) approval to allow export of a2 Milk's China label infant formula to continue. This was a significant step for the two companies, overcoming a regulatory hurdle that has caused issues for competitors of late as they seek ongoing access to the lucrative Chinese market. 

In addition to exporting to China, Synlait supplies products to Australia and New Zealand and is in the process of gaining FDA (Food and Drug Administration) approval to sell infant formula in the United States.

The US is the second-largest infant formula market after China, and Synlait would be just the second imported brand if granted registration. 

Infant formula production has become a key focus for Synlait and the company has invested significant capital to increase volume growth. The new site at Auckland and expanded Dunsandel facility is expected to alleviate previous capacity constraints by the second half of FY2018. 

By increasing its profitable infant formula business, Synlait seeks to improve softening margins that have hampered profit growth despite strong increases in revenue.

Statutory net profit after tax for FY2017 grew a relatively lean 11.20% on the back of a 38.80% rise in sales. A $100m capital raising during the year also reduced earnings per share while strengthening the company's growing balance sheet. 

Foolish takeaway 

The Australian share market is a big fan of infant formula suppliers to China and for good reason. Synlait appears to have its Chinese regulatory risks under control to date, while future FDA approval and a focus on improving profit margins could provide the catalyst for strong share price gains over the next 12 months. 

The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »